By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Arch Therapeutics 

1 Chieftain Lane

Natick  Massachusetts  01760  U.S.A.
Phone: 617-475-5254 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Arch Therapeutics To Present At The Biotech Showcase(TM) 2015 Conference On January 14th 2015 12/18/2014 9:48:56 AM
Arch Therapeutics To Present At LD Micro Main Event On December 4th 2014 11/26/2014 9:31:03 AM
Arch Therapeutics Reports Positive Preclinical Data From Study of AC5 Surgical Hemostatic Device™ In Animals Treated With Brilinta® (ticagrelor) 11/18/2014 1:15:28 PM
Arch Therapeutics Will Present At Two Investor Conferences In November 11/10/2014 9:02:06 AM
Arch Therapeutics Reports Positive Preclinical Data From Study Of AC5 Surgical Hemostatic Device™ In Animals Treated With The Antiplatelet Medications Plavix(R) (Clopidogrel) And Aspirin 11/6/2014 8:45:40 AM
Arch Therapeutics Negotiating a Collaboration Agreement With CURAM Centre For Research In Medical Devices 10/23/2014 10:50:42 AM
Arch Therapeutics Will Present At The Livingston Securities Life Sciences Stakeholders Summit On October 1, 2014 10/2/2014 12:35:28 PM
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke To Speak At 12th International Conference On Neuroprotective Agents On September 29 9/24/2014 12:02:07 PM
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke To Speak At 12th Annual Current Issues In Medicine, Biotech And Pharma Conference On September 18 9/17/2014 12:56:38 PM
Arch Therapeutics Announces Positive Preclinical Data From An Independent Study Of AC5 Surgical Hemostatic Device™ 9/8/2014 11:14:24 AM
1234
//-->